Approach to Managing Glaucoma
Definition and Pathophysiology
- Glaucoma is a chronic, progressive optic neuropathy characterized by damage to the optic nerve, death of retinal ganglion cells, and loss of retinal nerve fiber layer (RNFL), resulting in progressive visual field loss 3, 2
- It is the second leading cause of blindness worldwide after cataracts, with an estimated 76 million people affected globally in 2020 4, 2
- Primary open-angle glaucoma (POAG) is the most common form, characterized by open anterior chamber angles and optic nerve damage with or without elevated IOP 1, 5
Risk Factors
- Elevated intraocular pressure (IOP) - the only modifiable risk factor 2
- Older age 2
- Family history of glaucoma 2
- African race or Latino/Hispanic ethnicity 2
- Thin central corneal thickness 2
- Low ocular perfusion pressure 2
Diagnostic Approach
- Complete ocular history (refractive error, trauma, prior surgery) 1
- Family history of glaucoma, including severity and outcomes 1
- Systemic history (asthma/COPD, migraine, Raynaud's syndrome, diabetes, cardiovascular disease) 1
- Race/ethnicity assessment 1
- Intraocular pressure (IOP) measurement with multiple readings at different times of day 6
- Gonioscopy to assess anterior chamber angle and exclude angle closure or secondary causes 6
- Central corneal thickness (CCT) measurement, as thinner corneas are associated with higher risk of progression 6
- Optic nerve head (ONH) examination to identify structural changes 6
- Retinal nerve fiber layer (RNFL) assessment 6
- Visual field testing using standard automated perimetry (SAP) 1
- Structural imaging: Stereoscopic optic disc photography 6, Optical coherence tomography (OCT) of ONH, RNFL, and macular ganglion cell complex 6
Classification of Glaucoma Severity
- Mild: Definite optic disc, RNFL, or macular imaging abnormalities with normal visual field on standard automated perimetry 2
- Moderate: Definite optic disc, RNFL, or macular imaging abnormalities with visual field abnormalities in one hemifield not within 5 degrees of fixation 2
- Severe: Definite optic disc, RNFL, or macular imaging abnormalities with visual field abnormalities in both hemifields and/or loss within 5 degrees of fixation in at least one hemifield 2
Management Approach
- Control IOP in the target range 3
- Maintain stable optic nerve/RNFL status 3
- Preserve stable visual fields 3
- Maintain quality of vision and preserve quality of life 2
- Target IOP should be individualized based on stage of glaucoma damage, baseline IOP, age, and additional risk factors 2, 5
- Lowering pretreatment IOP by 25% or more has been shown to slow progression of POAG 5
Monitoring and Follow-up
- Untreated low-risk patients: Follow-up every 12-24 months 6
- Treated or high-risk patients: More frequent follow-up (every 3-6 months) until stable 6
- Each follow-up visit should include visual acuity measurement 2, slit-lamp biomicroscopy 8, IOP measurement 2, and periodic ONH and RNFL evaluation 6
Quality of Life Impact
- Glaucoma can significantly impact quality of life, affecting daily activities like reading, walking, and driving 4
- Performance deteriorates with worsening glaucoma severity or when both eyes are affected 4
- People with glaucoma are more likely to experience falls and motor vehicle collisions 4
- Direct medical costs for glaucoma in the US are estimated at nearly $3 billion annually 4